eHealth Ventures is proud to announce an investment in its latest portfolio company, RespirAI Medical, who is developing an innovative home monitoring AI platform to actively monitor patients suffering from multiple respiratory and other chronic diseases.
The mission of this game-changing device is to detect early exacerbations of chronic diseases, while enabling patients, their families, and care providers to improve disease management and patients’ quality of life. RespirAI is led by CEO Nimrod Bin-Nun and CTO Assaf Gur, two seasoned entrepreneurs with combined professional experience of over 30 years.
RespirAI’s wearable device is based on a novel biomarker (BioCoupling) which synchronizes between the breathing and walking of the patients and combines lung and pulse activity (BioCoupling), which was grounded in novel research from the University of Nebraska. This investment in RespirAI marks the first eHealth Ventures portfolio company based on non-Israeli IP that was licensed and “imported” by an Israeli entity.
The company’s CEO, Nimrod Bin-Nun, shares his excitement on the recent partnership with eHealth Ventures: “We are very happy to receive the support and funding from eHealth Ventures. eHealth Ventures digital-health focus, expertise and strategic connections will enable us to accelerate the development of our unique platform and expand our clinical efforts”.
Assaf Gur adds: “We are looking forward to introducing our breakthrough solution to the market and help millions of chronic patients around the world”.
eHealth Ventures is enthusiastic about the new investment, which is an innovative company in the up-in-coming Technology. eHealth Ventures VP BD Ophir Shahaf commented: “Home monitoring for lung diseases is an underserved area and we happy to invest in this innovative company, based on foreign IP, that will make full use of the funding and unique strategic support we provide. We see this field as a strong driver of growth, and we trust Assaf and Nimrod, an excellent management team, to lead RespirAI to success”.
About eHealth Ventures
The eHealth Ventures partnership is a leading investor in early-stage digital health companies.
It includes 2 VC funds and a technological incubator with an exclusive focus on digital health and significant government non-dilutive funding. Partners include Maccabi (a leading Israeli HMO), Amgen (global biotech giant), the Mayo Clinic, Medison Ventures, Arad Investments, and the Hadar Group. The team has reviewed over 1,650 companies to date and invested in a portfolio of 24 highly innovative companies (digital diagnostics, therapeutics, home care and Bioconvergence).